Parabilis Medicines, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Fog Pharmaceuticals, Inc. (to 2025)
0
Ending by 2030
Sep 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 5, 2027The maintenance fee for Agents modulating beta-catenin functions and methods thereof (US 11,834,482) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,198,713 | Agents modulating beta-catenin functions and methods thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,834,482 | Agents modulating beta-catenin functions and methods thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,398,178 | Collections of peptides, peptide agents, and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,759,973 | Amino Acids In force · High confidence | In force | High confidence | |
| US 12,760,298 | Technologies Useful for Assessing Permeability In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.